Skip to main content
. 2010 Oct 27;81(1):195–201. doi: 10.1016/j.ejrad.2010.09.040

Table 2.

Summary of HRCT morphology between groups (N = 183).

CT morphologya Group 1 Group 2
p-Valueb
(n = 84) 2a (n = 40) 2b (n = 27) 2c (n = 32)
Consolidation 72 (85.7) 14 (35.0) 3 (11.1) 28 (87.5) <.001*
Cavitation 51 (60.7) 7 (17.5) 2 (7.4) 3 (9.4) <.001*
Clusters of small nodules/mass 69 (82.1) 10 (25.0) 0 (0) 0 (0) <.001*
Septal thickening 55 (65.5) 18 (45.0) 2 (7.4) 12 (37.5) <.001*
Bronchial wall thickening 69 (82.1) 20 (50.0) 7 (25.9) 10 (31.3) <.001*
Ground glass opacity 74 (88.1) 27 (67.5) 11 (40.7) 22 (68.8) <.001*
Centrilobular nodules 43 (51.2) 35 (87.5) 5 (18.5) 21 (65.6) 0.156
Tree-in-bud 45 (53.6) 35 (87.5) 2 (7.4) 14 (43.8) 0.781
Paratracheal adenopathy 56 (66.7) 8 (20.0) 4 (14.8) 4 (12.5) <.001*
Fibrosis 2 (2.4) 11 (27.5) 17 (63.0) 0 (0) <.001*
Calcification 6 (7.1) 6 (15.0) 19 (70.4) 0 (0) 0.001*
a

Data are presented as numbers with percentage (%).

b

p-Value derived from the difference between group 1 and group 2 with Pearson's chi-square test or Fisher's exact test.

*

p-Value < 0.05.